Tonix Pharmaceuticals Holding Corp (TNXP) financials · rev $13.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Tonix Pharmaceuticals Holding Corp (TNXP) rev $13.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $13.1M | $10.1M |
| Cost of Revenue | $6.64M | $7.76M |
| Gross Profit | $6.47M | $2.33M |
| Operating Income | -$125.7M | -$136.7M |
| Net Income | -$124.0M | -$130.0M |
| EPS (Diluted) | -$14.57 | -$176.60 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $277.2M | $162.9M |
| Current Assets | $228.9M | $119.0M |
| Cash & Equivalents | $207.6M | $98.8M |
| Inventory | N/A | $8.41M |
| PP&E | $44.5M | $42.3M |
| Total Liabilities | $32.0M | $23.3M |
| Current Liabilities | $30.8M | $18.3M |
| Short-term Debt | N/A | $2.82M |
| Long-term Debt | N/A | $4.67M |
| Total Debt | N/A | $7.49M† |
| Shareholders' Equity | $245.2M | $139.6M |
| Retained Earnings | -$854.7M | -$730.7M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$99.8M | -$60.9M |
| CapEx | $3.37M | $120.0K |
| Investing Cash Flow | -$4.53M | -$120.0K |
| Financing Cash Flow | $214.5M | $134.9M |
| Net Change in Cash | $110.1M | $73.8M |
| Free Cash Flow | -$103.2M | -$61.0M |
FAQ
What is TNXP P/E and revenue?
Tonix Pharmaceuticals Holding Corp (TNXP) rev $13.1M.
What is TNXP revenue?
Tonix Pharmaceuticals Holding Corp last cached revenue is $13.1M (FY2025).
Is TNXP profitable?
Tonix Pharmaceuticals Holding Corp last cached net income is -$124.0M (FY2025).
What are TNXP total assets?
Tonix Pharmaceuticals Holding Corp last cached total assets are $277.2M (FY2025).
What is TNXP free cash flow?
Tonix Pharmaceuticals Holding Corp last cached free cash flow is -$103.2M (FY2025).
Not investment advice. Cached statements, not a live tape.